Praxis Precision Medicines Stock Performance

PRAX Stock  USD 335.28  3.67  1.11%   
Praxis Precision holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of -0.22, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Praxis Precision are expected to decrease at a much lower rate. During the bear market, Praxis Precision is likely to outperform the market. Use Praxis Precision potential upside, and the relationship between the jensen alpha and accumulation distribution , to analyze future returns on Praxis Precision.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
1.11
Five Day Return
6.36
Year To Date Return
17.07
Ten Year Return
(19.60)
All Time Return
(19.60)
Last Split Factor
1:15
Last Split Date
2023-11-29
1
TD Cowen Lifts Praxis Precision Medicines Inc. Price Target amid NDA for Essential Tremor Treatment
12/11/2025
2
Disposition of 405 shares by Souza Marcio of Praxis Precision at 292.63 subject to Rule 16b-3
01/07/2026
3
Insider Trading
01/08/2026
4
Disposition of 4252 shares by Souza Marcio of Praxis Precision at 288.45 subject to Rule 16b-3
01/09/2026
5
Why Praxis Precision Medicines Is Up 5.1 percent After Dual NDA Plans And Data Platform Expansion
02/03/2026
6
Is Praxis Precision Medicines Now Pricing In Recent Pipeline Progress And Volatile Share Gains
02/05/2026
7
Acquisition by Kindler Jeffrey B of 224 shares of Praxis Precision at 319.57 subject to Rule 16b-3
02/06/2026
8
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Co...
02/09/2026
9
Profund Advisors LLC Raises Stake in Praxis Precision Medicines, Inc. PRAX
02/13/2026
10
Earnings Outlook For Praxis Precision Medicine
02/18/2026
11
Praxis Precision Medicines Inc Q4 2025 Earnings Call Highlights Strong Financial ...
02/19/2026
12
Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results
02/20/2026
Begin Period Cash Flow215.8 M
Total Cashflows From Investing Activities-311.1 M

Praxis Precision Relative Risk vs. Return Landscape

If you would invest  19,086  in Praxis Precision Medicines on November 24, 2025 and sell it today you would earn a total of  14,442  from holding Praxis Precision Medicines or generate 75.67% return on investment over 90 days. Praxis Precision Medicines is currently generating 1.0518% in daily expected returns and assumes 5.2811% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Praxis, and 79% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Praxis Precision is expected to generate 7.14 times more return on investment than the market. However, the company is 7.14 times more volatile than its market benchmark. It trades about 0.2 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of risk.

Praxis Precision Target Price Odds to finish over Current Price

The tendency of Praxis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 335.28 90 days 335.28 
about 10.55
Based on a normal probability distribution, the odds of Praxis Precision to move above the current price in 90 days from now is about 10.55 (This Praxis Precision Medicines probability density function shows the probability of Praxis Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Praxis Precision Medicines has a beta of -0.22 indicating as returns on the benchmark increase, returns on holding Praxis Precision are expected to decrease at a much lower rate. During a bear market, however, Praxis Precision Medicines is likely to outperform the market. Moreover Praxis Precision Medicines has an alpha of 1.0467, implying that it can generate a 1.05 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Praxis Precision Price Density   
       Price  

Predictive Modules for Praxis Precision

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Praxis Precision Med. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
331.90337.18342.46
Details
Intrinsic
Valuation
LowRealHigh
301.75426.31431.59
Details
Naive
Forecast
LowNextHigh
326.40331.68336.96
Details
12 Analysts
Consensus
LowTargetHigh
549.07603.38669.75
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Praxis Precision. Your research has to be compared to or analyzed against Praxis Precision's peers to derive any actionable benefits. When done correctly, Praxis Precision's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Praxis Precision Med.

Praxis Precision Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Praxis Precision is not an exception. The market had few large corrections towards the Praxis Precision's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Praxis Precision Medicines, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Praxis Precision within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.05
β
Beta against Dow Jones-0.22
σ
Overall volatility
50.15
Ir
Information ratio 0.17

Praxis Precision Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Praxis Precision for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Praxis Precision Med can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Praxis Precision Med is way too risky over 90 days horizon
Praxis Precision Med appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 7.46 M. Net Loss for the year was (303.27 M) with loss before overhead, payroll, taxes, and interest of (238.43 M).
Praxis Precision Medicines currently holds about 165.4 M in cash with (249.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7.
Praxis Precision Med has a frail financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors
Latest headline from benzinga.com: Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results

Praxis Precision Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Praxis Stock often depends not only on the future outlook of the current and potential Praxis Precision's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Praxis Precision's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding22.5 M
Cash And Short Term Investments599.3 M

Praxis Precision Fundamentals Growth

Praxis Stock prices reflect investors' perceptions of the future prospects and financial health of Praxis Precision, and Praxis Precision fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Praxis Stock performance.

About Praxis Precision Performance

Evaluating Praxis Precision's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Praxis Precision has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Praxis Precision has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.32)(0.34)
Return On Capital Employed(0.37)(0.39)
Return On Assets(0.32)(0.34)
Return On Equity(0.35)(0.36)

Things to note about Praxis Precision Med performance evaluation

Checking the ongoing alerts about Praxis Precision for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Praxis Precision Med help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Praxis Precision Med is way too risky over 90 days horizon
Praxis Precision Med appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 7.46 M. Net Loss for the year was (303.27 M) with loss before overhead, payroll, taxes, and interest of (238.43 M).
Praxis Precision Medicines currently holds about 165.4 M in cash with (249.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7.
Praxis Precision Med has a frail financial position based on the latest SEC disclosures
Over 100.0% of the company shares are owned by institutional investors
Latest headline from benzinga.com: Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results
Evaluating Praxis Precision's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Praxis Precision's stock performance include:
  • Analyzing Praxis Precision's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Praxis Precision's stock is overvalued or undervalued compared to its peers.
  • Examining Praxis Precision's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Praxis Precision's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Praxis Precision's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Praxis Precision's stock. These opinions can provide insight into Praxis Precision's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Praxis Precision's stock performance is not an exact science, and many factors can impact Praxis Precision's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Praxis Stock Analysis

When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.